AARD vs AMZN · $284.4M cap vs P/E 31, rev $716.92B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Amazon.com Inc (AMZN) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
AARD currently screens at market cap $284.4M. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Not investment advice. Open the AARD and AMZN stock pages for the full models.
Not investment advice.